Revolution Medicines, Inc. (RVMD) Misses Q2 EPS by 19c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q2 EPS of ($1.31), $0.19 worse than the analyst estimate of ($1.12).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• List of suppliers, parts, photos of iPhone 18 Pro are part of Tata Electronics data breach - Reuters
• Liquidia Technologies (LQDA) 1K contracts of October 50 calls trade, share price down 5%
• Casey's General Stores (CASY) call put ratio 2.1 calls to 1 put with a focus on August 820 calls